View of ENDOTHELIAL DYSFUNCTION AND IMMUNE–FIBROTIC CROSSTALK AS CENTRAL DRIVERS OF POST-COVID PROGRESSION IN RHEUMATIC DISEASES

Return to Issue Details ENDOTHELIAL DYSFUNCTION AND IMMUNE–FIBROTIC CROSSTALK AS CENTRAL DRIVERS OF POST-COVID PROGRESSION IN RHEUMATIC DISEASES Download Download PDF